Blog

Why Pantothenic Acid Deficiency Almost Never Gets Diagnosed

Written by the Gelagen Editorial Desk at GeleagenMedically reviewed by Dr. Julie Russak, MD, FAADRevised October 1, 2026

Quick answer

Gelagen lists 5.2 mg of pantothenic acid per 2 gummies, 104% of the FDA's 5 mg Daily Value. NIH's Office of Dietary Supplements states that naturally occurring pantothenic acid deficiency in humans is rare outside severe malnutrition, because the nutrient is present in almost all foods. The handful of documented human cases come from World War II prisoner-of-war studies and experiments that deliberately blocked pantothenic acid metabolism with an antagonist — not from everyday diets. That rarity is worth knowing before reading "104% DV" as proof of anything about deficiency risk either way.

What does the Gelagen label show for pantothenic acid?

Per 2 gummies, Gelagen lists 5.2 mg of pantothenic acid, shown as 104% of the FDA's adult Daily Value of 5 mg: 5.2 ÷ 5 = 1.04, or 104%. That places the line just over 100%, similar to folate (110%) and well below the panel's highest lines, biotin (16,667%) and B12 (250%). The full breakdown is on the Supplement Facts page.

6-bottle pack of Gelagen skin health gummies — At 104% DV, Gelagen's pantothenic acid line sits just over the FDA Daily Value — a reference built from usual healthy intake, not from a documented deficiency threshold.

Pantothenic acid, also known as vitamin B5, is a water-soluble B vitamin whose main job in the body is building coenzyme A (CoA) and acyl carrier protein. NIH describes CoA as "essential for fatty acid synthesis and degradation, transfer of acetyl and acyl groups, and a multitude of other anabolic and catabolic processes" — in plain terms, it is a core piece of equipment the body's metabolism runs on constantly, not a niche compound with a narrow job. About 85% of dietary pantothenic acid arrives already bound up as CoA or phosphopantetheine, which digestive enzymes then convert back to free pantothenic acid for absorption. A wide variety of plant and animal foods contain it, which is also the starting point for why deficiency is so uncommon.

A line reading "just over 100%" can look like it is answering a clinical question — "does this cover what I need to avoid a deficiency" — when the reference figure behind it was built a different way, and the deficiency it is implicitly guarding against is one of the least-documented in human nutrition.

Why is pantothenic acid deficiency considered rare?

NIH's Office of Dietary Supplements states the finding plainly: "because some pantothenic acid is present in almost all foods, deficiency is rare except in people with severe malnutrition." Pantothenic acid (vitamin B5) is used by the body to synthesize coenzyme A, a compound central to fatty acid metabolism and a wide range of other biochemical reactions — and because it shows up across plant and animal foods alike, a diet would have to be unusually restricted to fall short.

The same fact sheet adds a second reason deficiency is hard to pin down even when it happens: "when someone has a pantothenic acid deficiency, it is usually accompanied by deficiencies in other nutrients, making it difficult to identify the effects that are specific to pantothenic acid deficiency." In real-world malnutrition, pantothenic acid rarely runs short on its own — it runs short alongside protein, other B vitamins, and overall calories, which muddies any attempt to isolate what pantothenic acid alone was responsible for.

What are the actual documented human cases?

NIH's fact sheet is specific about where the evidence comes from: "the only individuals known to have developed pantothenic acid deficiency were fed diets containing virtually no pantothenic acid or were taking a pantothenic acid metabolic antagonist." It goes on: "on the basis of the experiences of prisoners of war in World War II and studies of diets lacking pantothenic acid in conjunction with administration of an antagonist of pantothenic acid metabolism, a deficiency is associated with numbness and burning of the hands and feet, headache, fatigue, irritability, restlessness, disturbed sleep, and gastrointestinal disturbances."

One of the controlled studies behind this picture is a 1958 paper by Hodges, Ohlson and Bean, "Pantothenic Acid Deficiency in Man," published in the Journal of Clinical Investigation. The researchers induced deficiency in volunteers using a semi-purified, pantothenic-acid-free diet together with a metabolic antagonist of the vitamin, then documented the resulting symptoms. A related 1962 paper by the same research group, published in the American Journal of Clinical Nutrition, looked at immune responses — specifically antibody responses — in the same deliberately deficient men.

Documented human pantothenic acid deficiency studies
Study	Method	What it found
Hodges, Ohlson & Bean, 1958 (J Clin Invest)	Pantothenic-acid-free diet plus a metabolic antagonist, in volunteers	First controlled description of deficiency symptoms in healthy men
Hodges, Bean, Ohlson & Bleiler, 1962 (Am J Clin Nutr)	Same deliberately induced deficiency model	Looked at antibody and immune responses in deficient men
World War II POW observations	Severe, uncontrolled wartime malnutrition	Clinical basis for associating symptoms with the deficiency, outside lab conditions

Outside of these sources — deliberately induced deficiency in research volunteers, and the extreme malnutrition of wartime captivity — NIH's own fact sheet does not point to a body of cases of naturally occurring pantothenic acid deficiency in otherwise normally-fed people.

What did a deficiency look like in those studies?

Per NIH's summary of the induced-deficiency and wartime evidence, the symptoms associated with pantothenic acid deficiency included numbness and burning of the hands and feet, headache, fatigue, irritability, restlessness, disturbed sleep, and gastrointestinal disturbances. None of these are specific to pantothenic acid on their own — which is part of why, outside a deliberately controlled research diet, attributing them to this one nutrient specifically is difficult in practice.

This is also why pantothenic acid deficiency does not have the kind of single, unmistakable clinical picture that, say, vitamin C deficiency has with scurvy, or thiamin deficiency has with beriberi. Those conditions were identified and named well before modern nutrition science because they produced a distinctive, severe, and relatively isolated set of findings. Pantothenic acid's deficiency picture, by contrast, was mostly characterized under laboratory conditions designed specifically to produce it.

Why is the reference an Adequate Intake, not an RDA?

The 5 mg figure behind Gelagen's 104% DV is an Adequate Intake (AI), not a Recommended Dietary Allowance (RDA). NIH explains the distinction for pantothenic acid specifically: "the FNB evaluated the available data, it found the data insufficient to derive an EAR for pantothenic acid. Consequently, the FNB established AIs for all ages based on usual pantothenic acid intakes in healthy populations."

That is a meaningfully different kind of reference figure than an RDA. An RDA is built from an Estimated Average Requirement, usually anchored to evidence about how much of a nutrient prevents a defined deficiency state in a defined share of the population. An AI, by contrast, is set from what healthy people typically already eat, used precisely in cases — like pantothenic acid — where the deficiency evidence needed to build an EAR does not really exist. In other words, the 5 mg figure was not derived by finding the point where pantothenic acid deficiency starts; it was derived by observing that healthy people eating ordinary diets tend to get around 5 mg, which happens to track with an almost total absence of deficiency in that same population.

Pantothenic acid Adequate Intake (AI), ages 19+
Group	AI
Adult men and women (19+)	5 mg/day
Pregnancy	6 mg/day
Lactation	7 mg/day

Who does NIH actually list as at risk of pantothenic acid inadequacy?

NIH's fact sheet includes a section on groups at risk of pantothenic acid inadequacy, and it names exactly one: people with a PANK2 gene mutation, which causes a rare inherited disorder called pantothenate kinase-associated neurodegeneration (PKAN). Pantothenate kinase is the enzyme that starts the conversion of pantothenic acid into coenzyme A; when PANK2 mutations reduce that enzyme's activity, CoA production can fall even when dietary pantothenic acid intake is normal. PKAN's effects can include dystonia, spasticity and pigmentary retinopathy, and NIH notes the condition progresses rapidly toward significant disability. Whether pantothenic acid supplementation helps is not established; some anecdotal reports describe symptom reduction in atypical PKAN, but this is a genetic metabolic condition, not a dietary shortfall a gummy's ingredient panel is positioned to address.

The practical point: NIH's own "who is at risk" list for this nutrient is not built around ordinary diets at all, low-calorie diets, or common deficiency patterns the way it might be for, say, iron or vitamin D. It is built around a single rare genetic condition that changes how the body processes pantothenic acid internally, independent of intake. That reinforces the broader picture — for the overwhelming majority of people checking a label, "deficiency risk" for this specific nutrient is not really the operative question a %DV figure is answering.

What does this mean for reading "104% DV" on this panel?

Three things are worth holding separately when a label shows a pantothenic acid line just over 100% of its Daily Value:

104% DV says the amount is slightly above a usual-intake-based reference figure — not that it is calibrated against a documented deficiency threshold.
Naturally occurring deficiency in a normally fed adult is, by NIH's own account, essentially unseen outside severe malnutrition.
The clearest human evidence for what a deficiency even looks like comes from studies that deliberately blocked the vitamin's metabolism with an antagonist, not from everyday nutrition.

None of this means the pantothenic acid line on this panel is doing nothing — coenzyme A, which pantothenic acid builds, is used throughout normal metabolism regardless of how rare an outright deficiency is. The narrower point is about what "104%" can and cannot tell a reader: it is a comparison to a usual-intake estimate, not a verdict on deficiency risk, because for this particular nutrient, deficiency risk in a normally fed adult is not really something the available human evidence measures.

Pantothenic acid deficiency: common questions

Is pantothenic acid deficiency common?

No. NIH's Office of Dietary Supplements describes it as rare outside severe malnutrition, because the nutrient is present in almost all foods.

How was human pantothenic acid deficiency actually studied?

The clearest evidence comes from research that deliberately fed volunteers a pantothenic-acid-free diet alongside a metabolic antagonist, documented in a 1958 study by Hodges, Ohlson and Bean, plus observations from World War II prisoners of war.

What were the symptoms in those studies?

Numbness and burning in the hands and feet, headache, fatigue, irritability, restlessness, disturbed sleep, and gastrointestinal disturbances, per NIH's summary of the available evidence.

Is the 5 mg Daily Value based on deficiency research?

No. It is an Adequate Intake based on usual pantothenic acid intake in healthy populations, set because the data needed to calculate a deficiency-based requirement were not available.

Does 104% DV mean Gelagen fully prevents any deficiency risk?

The figure means the amount is slightly above the usual-intake reference. Since naturally occurring deficiency is already rare in normally fed adults, the practical relevance of crossing 100% on this specific line is limited either way.

Who does NIH list as actually at risk of inadequacy?

NIH names one group: people with a PANK2 gene mutation, which causes the rare inherited condition PKAN. This is a genetic metabolic disorder, not a dietary deficiency pattern a supplement panel is designed to address.

Where can I see the full Gelagen panel?

The Supplement Facts page lists all 13 ingredients, amounts and %DV figures, including the pantothenic acid line discussed here.

References

Hodges RE, Ohlson MA, Bean WB (1958), Pantothenic Acid Deficiency in Man. Journal of Clinical Investigation 37(11):1642-1657.
Hodges RE, Bean WB, Ohlson MA, Bleiler RE (1962), Factors Affecting Human Antibody Response. III. Immunologic Responses of Men Deficient in Pantothenic Acid. American Journal of Clinical Nutrition 11:85-93.
NIH Office of Dietary Supplements (accessed 2026), Pantothenic Acid: Fact Sheet for Health Professionals.

Ready when you are

Order Gelagen from the authorized outlet

$49 to $79 a bottle, 60 gummies each. Every order has a 60-day money-back guarantee. Questions before you buy? The contact page says which desk answers what.

Order Gelagen Compare packs

Keep reading

Formula